跳至主要内容
临床试验/IRCT2015082111335N6
IRCT2015082111335N6已完成2 期

The effect of cholecalciferol supplementation on serum levels of vascular endothelial growth factor-A and angiopoietin-2 in breast cancer patients co-administered with tamoxifen: a randomized controlled clinical trial

Tabriz University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 65 years(—)
性别
Female

入选标准

  • The range of body mass index (BMI) is 20 to 35 kg/m2
  • 30 – 65 years old
  • histopathologic confirmed breast malignancy
  • histopathologic grades of 2 and 3
  • tendency to participate in study
  • completed questionnaire
  • tamoxifen consumption

排除标准

  • Being at clinical stage 4
  • acute renal or liver failure
  • using antiepileptic medications and contraceptive drugs
  • history of hormonal related diseases (such as diabetes, hyperthyroidism and poly cystic ovary syndrome)

研究者

相似试验

The effect of cholecalciferol supplementation on... | 临床试验